Clinical Trial Update: CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration [Phase 3]

View source ↗

Summary

Phase 3 trial update for CB-PRP in retinitis pigmentosa and dry age-related macular degeneration (AREDS) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration
• Retinitis Pigmentosa

Drugs mentioned

• CB-PRP

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Retinitis Pigmentosa, Dry Age-related Macular Degeneration | Phase 3 | Status: COMPLETED